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Summary
A gene responsible for facioscapulohumeral muscular dys­
trophy (FSHD) has been localized at 4q35. Subsequently, 
it was found that probe pl3E-ll detects a polymorphic 
EcoRI fragment, usually >28 kb, in normal individuals, 
whereas in sporadic and familial FSHD cases, an EcoRl 
fragment, usually <28 kb, was found. Although these 
findings have been amply confirmed, several aspects are as 
yet either controversial or unsolved. In the present inves­
tigation, 34 Brazilian FSHD families were studied at the 
clinical and the molecular level for the following 
purposes: to assess the frequency of new mutations and 
their effect on estimates of biological fitness, to character-
teristically affects the facial and shoulder girdle muscles, 
although there is a marked infra- and interfamilial variabil­
ity in expression. The penetrancc of the gene has been es­
timated at 95% for patients aged >20 years (Lunt et al. 
1989), and life expectancy is almost normal (Padberg 1982; 
Munsat 1986).
The gene responsible for FSHD was localized to 4q35 
by linkage with polymorphic markers (Wijmenga et al. 
1991, 1992/?), These findings were confirmed by several 
other groups worldwide (Sarfarazi et al. 1992; Passos- 
Bueno et al. 1993), although genetic heterogeneity seems 
to occur in some families (Gilbert et ah 1993; Iqbal et al. 
1992; Bakker et al., in press). Subsequently, it was ob-
ize FSHD-associated EcoRl fragments detected with probe served tha|C in normal individuals, the probe P13E-11 de- 
pl3E-ll in familial— as compared with isolated— FSHD
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cases, and to assess whether anticipation occurs in multi- kb’ whereas m KSHD families a specific shorter fragment,
generational families. Results from our study suggest that usuf 1 ^  '14 nnd 28 ^  io«nd fa cosegrcgate
new mutations are apparently frequent for FSHD and W1^  (Wijmenga ct a . 2a, assos-kieno ct a .
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may account for at least one-third of the cases, that so- 1993), Characterization of the polymorphic fragments
matic mosaicism may not be rare, and that biological fit- demonstiates that they consist of multiple copies of a 3.3-
ness appeared to be reduced in FSHD, ranging from 0.6 to kb tandem tepeat and that in hSHD patients an integial
0.82 by different estimates, with no difference in sexes. nuinbei o( these tandem lepeats ate deleted (Wijmenga ct
Interestingly, the size of the new EcoRl fragment is appar- 1993),
ently smaller in more severely affected isolated patients. Recent analysis of KSHD families raised several clinical,
Moreover, the age at onset of clinical signs, as well as the genetic, and molecular questions. If the frequency of a
age at ascertainment, in patients from multigenerational 
families suggests that anticipation occurs for FSHD in the
majority of the families.
Introduction
Facioscapulohumeral muscular dystrophy (FSHD) is an au 
tosomal dominant neuromuscular condition that eharac
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condition does not vary from generation to generation, the 
number of cases arising as a result of new mutations should 
be equal to the number that is eliminated because of re­
duced fitness. Since FSHD is apparently compatible with 
normal fertility, Morton and Chung(1959) predicted a low 
mutation frequency in this disease,
However, recent DNA studies suggest that new muta­
tions may not be rare for FSHD (Wijmenga ct al. .1992*7» 
Griggs et al. 1993). Although it is well established that de­
letions lead to FSHD, it is not known whether there is a 
correlation between the size of the EcoRl fragment de­
tected with pl3E-ll and the severity of the phenotype or 
whether k differs in inherited cases as compared with cases 
that have arisen through new mutations,
The occurrence of anticipation, that is, an earlier onset 
with increase in the severity of clinical symptoms in subse­
quent generations, has been investigated recently for sev­
eral conditions with variable expression (Aslanidis et al.
99
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1992; Buxton et al, 1992; Harley et ai. 1992; MacDonald 
et al. 1993; On* et al. 1993). This phenomenon has appar­
ently not been reported in the case of FSHD. Here we re­
port on these intriguing questions based on the results of 
34 FSHD families that were clinically, neurologically, and 
genetically investigated.
Patients and Methods
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Patients
Patients and families were studied at the Centro de Mi- 
opatias, Universidade de Sao Paulo. Patients (at least one 
from each family) as well as at-risk relatives (parents, sibs, 
and offspring of affected patients) were clinically and neu­
rologically examined in our center. The diagnosis was 
based on clinical and family history, electromyography, 
and muscle biopsy, following the four main criteria defined 
by the International FSHD Consortium (Padberg et al.
1991). Of the 34 families examined, 19 were multigenera- 
tional, while in 15 the pro band was the first case in the 
family. Patients’ relatives were classified as nonaffected if 
they had no clinical signs of FSHD and were >20 years of 
age and as “at risk” if they were <20 years of age.
For adults, the age at onset was estimated as the age 
when the patient first noticed any evidence of muscular 
weakness and, for affected children, when the patients5 
parents first observed any sign of FSHD. Whenever possi-
ble, this information was confirmed by the referring phys- pSHD locus (sarfarazi et al. 1992), excluded this locus as 
ician and by other relatives. Patients in whom the neuro- responsible for the FSHD phenotype in this particular fam- 
logical examination showed some pathological signs but ^  score = —2.8 at 0 = .01). A second two-generation
who weie still asymptomatic weie not included in the anal- family was excluded because a 30-kb EcoRl fragment de-
ysis. Age at ascertainment was estimated as the first time tected in the first DNA analysis was not seen in subsequent 
the family visited our center and the patient displayed clin- blots; hl the third famil ln which the band was an
Figure I Southern blot analyses of EcoRI-digested DNA hybrid­
ized to probe pl3E-l 1 in affected patients from a three-generation family. 
All patients show the samc-size 23-kb fragment, which is considered as 
the linked FSHD band. The other bands (>48 kb and 9.5 kb) are not 
specific to chromosome 4 (see text).
ically defined symptoms.
Molecular Genetic Analysis Technology 
DNA was extracted from whole blood according to the
isolated case, three bands were seen, and it was not possi­
ble to establish which of the EcoRi fragments was associ­
ated with FSHD,
Thirty-one FSHD genealogies have, therefore, been in-
method of Millet et al. (1988) and was digested with EcoRl duded in the present study. Among them, 17 were familial 
and electropnoresed in a 0.5% agarose gel, as reported pre­
viously (Passos-Bueno et al, 1990/?). Analysis of the poly­
cases, and in 14 the proband was the first case in the family. 
Students1 ¿-tests (paired and unpaired) and %2 analysis were
morphism detected by probe pl3E-l 1 was performed ac- usec, f()r statisticai analysis, as d m iled in Resuits. 
cording to the method of wijmcnga et al. ( 1992«) and 
Passos-Bueno et al. (1993).
DNA was analyzed for a total of 155 individuals (from 
the 34 genealogies) who had been clinically and neurolog- Analysis of the Eco RI Fragment
Results
ically examined: 77 were clinically affected, 24 were at risk, 
and 54 were nonaffected. DNA analysis was repeated at 
least twice in all the isolated and almost all the familial
Although the size of the pl3E-l 1 EcoRl fragment varied 
from one family to another, in all familial cases the same­
sized fragment was segregating among affected patients
cases and was included in the analysis only when con- within each individual family (fig, 1), An EcoRl fragment
firmed on independent blots. of <30 kb was observed in every case among the isolated
Three families in which clinical findings were compati- cases, (fig. 2). The size of theEcoRI fragment was, on aver-
ble with FSHD were excluded for the following reasons: In age, larger in familial cases (22 kb ± 4.8, n = 17) than in
one two-generation family, no small EcoRl fragment was isolated cases (18 kb ± 5.5, n = 14), but statistical analysis
found in the affected patients. Analysis of the family with showed only a borderline level of significance (i = 2.09; P
the VNTR marker D4S163, which is closely linked to the = .05).
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parents, suggesting that she carried a new mutation. DNA 
analysis showed a strong 15-kb EcolU band in this pro­
band, Interestingly, a band of the same size— but ex­
tremely faint— was detected in her unaftected mother, in 
independent blots, suggesting maternal mosaicism (fig. 3).
Analysis of Anticipation
In order to assess whether anticipation occurs in multi- 
generational families, the age at onset, as well as age at 
ascertainment (table 1), was estimated for the affected off­
spring and was compared with those of their affected par­
ents, with (a) all subjects (unpaired /-test) and (b) pairs (n 
= 28) of affected parent/child (paired /-test) taken into 
account. On average, the onset of clinical signs (as well 
as the ascertainment) occurred significantly earlier in the 
affected offspring as compared with their parents, consid­
ering all subjects or pairs of affected parent/child. In 
multigenerational families, the difference in the mean age 
at onset, between parents (32,3 years) and offspring (15.0 
years), was 17.3 years, while the difference in the mean age 
at ascertainment, between parents (51.2 years) and off­
spring (26.1 years), was 25.1 years.
In order to verify whether such differences could be due 
to a bias of ascertainment, since more severely affected 
propositi are more likely to be ascertained, statistical anal-
To estimate the proportion of cases due to new muta- was repeated excluding the index case from each fam-
tions, two parameters were taken into consideration: (a) ily. As seen in table 1, the statistically significant differences
the number of normal sibs of the index case and (h) the wcrc confirmed, both for age at onset and forage at ascer-
analysis of the novel EcoRl fragment in the proband and tainment, for affected parents when compared with their
in the parents. For this analysis 3 of 14 families were ex- affected offspring,
9 . 5 mm
Figure 2 Southern blot analyses of ftroRI-digested DNA hybrid­
ized to probe pl3E-l 1 in an isolated case. The novel LVoRI fragment 
present in the patient is not seen in the unaffected parents. The other 
bands (>48 kb nnd 9.5 kb) are not specific to chromosome 4 (see text).
eluded; in 2 families, the proband’s parents were not avail- In order to assess whether the gender of the transmitting
able, making it impossible to determine whether a new Parent could influence the age at onset iti affected ofi-
mutation had occurred, and in the third case, where the 
father could not be tested, the proband’s mother and three 
apparently normal sibs who were tested did not carry the 
novel EcoRl fragment present in the propositus. However, 
three other sibs (two of them <20 years of age) could not 
be tested.
In 7 of the 11 remaining families, both parents were 
tested, and none of them have the small EcoRl fragment 
observed in the index case. In the other four families, the 
parents were deceased or not available but were inferred 
(by their physician or relatives) to be unaffected. In these 
families, the probability of new mutation events is high (P 
> .98), because the probands have 6 to 10 normal sibs, all 
>20 years of age. Therefore, when the number of un­
affected individuals in each family is taken into account, 
together with the results of DNA, it was estimated that 
new mutations are highly probable in 11 of the 14 isolated
Kb
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One particular family caught our attention. The pro- 
band, a 30-year-old female patient, showed a typical FSH.D 
phenotype with considerable weakness of her face and up- 
pcr-limb musculature. She had three unaffected sibs, and 
clinical examination did not reveal any weakness in her
Figure 3 Maternal mosaicism showing that the same strong 15- 
kb lit'oR I fragment seen in the ull'ecied proband is present as a faint hand 
(dm«/') in her unaffected mot her. The same results were obtained in three 
dilferent blots in which the DNA concentrations wore comparable for all 
subjects in this family (data not shown).
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Table I
Mean Ages at Onset and at Ascertainment in FSHD Families
Age at Age at
Onset*1 Ascertainment1 
Group (N) (years) (years)
A. Familial cases: total sample:
1. Parents(17 )................................  32.3 ± 19.8 51.2 ± 13.7
2. Offspring (37) .............................  15.0 ± 5.8 26.1 ± 9.8
B. Familial cases: without probands:
1, Parents(14 )................................ ...... 34.4±21.1 54.1 ± 13.0
2, Offspring (24)................................... 15.4± 5.6 26.4 ± 10.6
3, Probands (17)...... ..................... ...... 15.8 ± 7.1 27.6 ± 9,0
C. Isolated cases (14) ........... *......>.... 14.5 ± 9.5 27.2 ± 11.0
1 By impaired t-test, differences between groups A .l and A,2 (t ~ 4.9; 
P <  .01) and between groups B.l and B,2 (t - 4.2; P <  .01) are highly 
significant whereas differences between groups B.2 and B.3 (i — —,19; P
> ,05) and between groups B.3 and C (t = —.45; P >  .05) are not statisti­
cally significant; by paired ¿-test, differences between A .l and A.2 are 
highly significant (i — 8.9; P <  .01).
b By unpaired /-test, differences between groups A .l and A.2 [t ~ 7.8; 
P < .01) and between groups B.l and B.2 [t = 7.8; P <  .01) are highly 
significant whereas differences between groups B.2 and B.3 (t — —.36; P
>  .05) and between groups B.3 and C (t = —.12; P >  ,05) are not statisti­
cally significant; by paired f-test, differences between A .l and A.2 arc 
highly significant (t ~ 18,2; P <  .01).
itus1 descendants were affected), which led to a fitness es­
timate of 0.6 {32/.53)
spring, patients born from affected mothers were com-
Discussion
Proportion of New Mutations and Somatic Mosaicism
Somatic and/or germinal mosaicism has been reported 
for several genetic diseases (Maddalena et al. 1987; Bakker 
et al. 1989; Brocker-Vriends et al. 1990; Passos-Bueno et 
al. 1990tf). For Duchenne muscular dystrophy (DMD), it 
has been shown that the frequency of cases resulting from 
germinal mosaicism depends on the site of the deletion in 
the dystrophin gene (Passos-Bueno et al. 1992).
Somatic mosaicism has been previously reported for 
FSHD (Griggs et al. 1993; Weiffenbach et al. 1993), but its 
frequency is still unknown. It would be of interest to assess 
whether the mosaicism detected in peripheral blood in the 
propositus5 mothers from the present study is also present 
in other tissues, in particular in skeletal muscle. However, 
such an analysis requires a muscle biopsy, which is difficult 
to obtain in the present case. The fact that the transmitting 
mother is clinically asymptomatic does not allow any spec­
ulation about the proportion of muscular cells potentially 
carrying the defective gene, since subclinical cases are 
known for individuals from proved chromosome 4q- 
linked families.
The present observation of one mosaic case of seven in 
which both parents could be studied suggests that it might
pared with those born from affected fathers. No statisti- , „. c r c u n  i * r -i a- • \ .
r not be rare ror FSHD, but further studies are required to
cally significant differences were observed between the
confirm this hypothesis. Such findings, in addition to being
two groups: the age at onset was 14.5 ± 6*31 years (« = 20) • v r
r * x ^  r indicative or somatic origin ror new mutations, are impor-
ror group 1 and 15.7 ± 5.92 years [n = 17) ror group 2 it . „ c • i i i i i i r
r \ tant ror recurrence-nsic calculations, as already shown ror
= ,6; P > .05),
DMD (Passos-Bueno et al. 1992).
The large proportion of isolated cases (14/31, or 45%) 
in the total sample called our attention, because the pro- 
Biological fitness was estimated by means of two ap- portion of cases resulting from new mutations had pre-
Fitness Estimate
proaches. The first involves calculating the total number 
of children bom from all affected patients, as compared 
with the total number of children born from their normal
viously been assumed to be very low (Morton and Chung 
'1959; Thompson 1986). Our results, however, suggest that 
new mutations are not rare and may account for at least
unaffected sibs of comparable age (all were >20 years of one-third of the cases. This observation supports the orig-
age). In this analysis, 29 families were included. The aver- inal report by Wijmenga et al. (1992a) who detected de
age number of children of FSHD patients was 1.86 (104/ novo rearrangements in 5 of 15 FSHD families, in which 6
56) as compared with 2.26 (276/122) for their normal sibs, were isolated cases, although this sample was the first to
which led to a fitness of 0.82 (1.86/2.26), with no differ- be studied and might not be representative of the Dutch
ence between sexes (0.81 for affected females and 0.84 for population. Recently, Griggs et al. (1993) reported the oc-
affecled males). currcnce of new mutations in eight sporadic FSHD pa-
ents.
The second approach is a simple method proposed by tients, on the basis of clinical findings and the analysis of
Tanaka (1974), which is particularly valuable for autoso- the novel EcoRl fragment in the probands and in their par- 
mal dominant disorders (Emery 1976), where f  = Ap/A (,
(Ap = frequency of the trait among parents of index cases; Finding a relatively high proportion of new mutations is
and A0 = frequency of the trait among offspring of index not compatible with previous studies, which reported high
cases). In this analysis, 14 three-generation families in fertility (Morton and Chung 1959) and apparently normal
which the probands’ descendants were >20 years of age fitness for FSHD (Eggers et al. 1993). According to Emery
were included. It was found that Ap = *32 (9 of 28 propos­
itus’ parents were affected) and An = .53 (27 of 51 propos-
(1976), however, a reliable estimate of biological fitness is 
difficult to determine, because of insufficient data. In some
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of the earlier studies, the clinical overlap of limb-girdle suggested a causal relationship between the rearrangement
cases with cases of scapulohumeral onset led some investi- and the appearance of FSHD (Wijnienga et al. 1990,
gators to pool both types into a single group. In the case 1992d). The rearrangement was shown to be due to dele-
of FSHD, previous estimates of normal fitness, including tion of integral copies of the 3.3-kb repeat unit (van Deu-
our own earlier study (Eggers et aL 1993), were based on tekom et ah, in press). The most straightforward explana-
multigenerational families only. However, when we reana- tion is that the FSHD gene is structurally affected through
lyzed the reproductive performance of affected patients, the deletion. There are, however, several observations
including the isolated cases, according to the method of making this model less obvious, suggesting a functional
Tanaka (1974), we found a reduction in biological fitness, rather than a structural dysfunction of the FSHD gene.
This method is based on the principle that if selection Several cases of apparent affected recombinants in FSHD
against a specific disorder is sufficiently strong, the fre- families with no small fragment have been reported (llpad-
quency of affected individuals among parents of index hyayaetal. 1,993; Weiffenbach et al. 1993). Although sev-
cases will be lower than that among the offspring of index oral of these recombinants could reflect diagnostic misclas-
cases and that this reduction is proportional to the inten- sifications, a few have withstood severe scrutiny, These re-
sity of selection. The advantage of this method is that it 
takes into account the cases that have arisen from new
combinants can be accounted for by intragenic and 
interfocus recombination events or by other, as yet un
estingly enough, according to Morton and Chung (1959), 
although FSHD is compatible with high fertility, they also 
estimated a reduced fitness of ^0.736 for this condition.
mutations and not the total number of descendants. Inter- identified, mechanisms (Wijmenga et al. 1993; Winokur et
al. 1994).
Analysis of the pl3E-ll locus has revealed it to be very 
close to the telomere and to contain sequences often en- 
In view of the unexpectedly significant proportion of countered in heterochromatic regions (Hewitt et al. 1994; 
isolated cases, it would be important to have fitness reas- Winokur et al. 1994). These observations are in line with a 
sessed in FSHD patients from other populations, through position-variegation effect involved in the etiology of 
different methods, with an effort being made, whenever psHD and might suggest that the FSHD gene is located 
possible, to see all patients within a given population. In either upstream or downstream of the EcoRl fragment. So 
any case, the observation that new mutations are not rare far? no sjgns Df transcriptional activity have been found in 
for FSHD has important implications for clinical diagnosis the telomeric part. As the search for a transcript within
« i >1 * « ft 1 ■ -I I
and genetic counseling, in particular of isolated cases.
Analysis of the EcoRl Fragments
The present report supports previous studies showing 
that in 31 Brazilian families, the clinical picture of FSHD ^ . ...
is caused by a gene located at 4q35, closely linked with ,mca ana 1
the repeat units has been unsuccessful, the position effect 
deserves attention. Consequently, the gene search should 
be directed upstream.
EcoRl fragments ranging from 10.5 to 33 kb. Probe pl3E- 
11 detects polymorphic restriction fragments from several
The great variability in the severity of the phenotype, a 
well-known characteristic of FSHD, was also confirmed in
loci, some of which are difficult to resolve by conventional our study» with the age at onset of clinical signs ranging
agarose gel electrophoresis (Wijmenga et al, 1994). Only a from 2 to 50 years. In two unrelated mult ¡generational
number of these loci have been chromosomally mapped. families with multiple a fleeted patients, the gene was no n-
A 9.5-kb fragment appears only in males and consequently penetrant, since parents of affected patients (a lomale aged
maps to the Y chromosome. In the largest size range, two 46 years and a male aged 79 years), who were the proved
polymorphic loci can be visualized by pulscd-field gel dec- transmitters of the FSHD gene (through pedigree analysis,
trophoresis. Recently we were able to map the second lo- since both had clinically affected sibs), were asymptomatic
eus to the long arm of chromosome 10, in the region q35 011 clinical examination. In both families, the same specific
(Bakker et al., in press). Interestingly, the average size of EcoRl fragment found in affected patients was present in 
the lOq fragments is smaller than the average size of the asymptomatic carriers of the FSHD gene. I he occur-
4q fragments (Wijmenga et al. 1994). As FSHD is usually renee of a nonpenetrant case of FSHD in a 6 1-year-old
associated with small (<30 kb) EcoRI fragments, this sec- female was also recently reported by Griggs et al, (1993).
A « a jAI » * a /* I t ■
ond locus may hamper the interpretation of conventional 
Southern blots and forms a serious caveat for FSHD diag­
nosis in small families. For diagnostic purposes, haplotyp- 
ing with 4q and lOq markers might help.
Recombinant/Rosition Effect
The difference in the average size of the fragment in iso­
lated cases, as compared with familial cases, although 
smaller in the former group, showed a borderline level of 
significance. However, when the size of the fragment was 
analyzed in relation to the severity of the phenotype 
among isolated cases, we observed that among the more
The observation of both the new “small” EcoRl frag- severely affected patients (onset before the age of 10 years) 
ments in new FSHD patients and cosegregation in families the average size of their EcoRl fragment (12.9 kb ± 2.0, n
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4) was significantly smaller than that among patients ment, between the probands in familial cases, as compared
with later onset (20.0 ± 5.7 kb, n = 10, P < .01). with isolated cases (table 1). This observation supports
These differences were surprising, since within each prior knowledge that more severely affected cases are more
multigenerational family, the same-size EcoRl fragment is likely to come to medical attention earlier and that iso-
segregating in patients with different degrees of clinical se- lated cases with visible symptoms seek medical help at the
verity. Although the number of patients is small, and this same age, on average, as do familial cases. We are aware,
result should be confirmed in a larger sample, it suggests however, that we are probably not ascertaining isolated
that smaller fragments may be associated with a more se- patients with a mild phenotype. Results from the present
vere phenotype. 
Analysis of Anticipation
study are yet to be confirmed in a larger sample of FSHD 
families from different populations. Revealing the molecu­
lar defect in FSHD is of great importance to elucidate the
Anticipation is a phenomenon that has been extensively relationship between genotype and phenotype, 
described for myotonic dystrophy (DM) and other condi-
Acknowledgmentstions, such as Huntington disease (HD) and spinocerebel­
lar ataxia (MacDonald et ah 1993; Orr et aL 1993), that 
have both an increase in severity and earlier age at onset 
in successive generations. In the present sample, with the 
exception of one family in which the mother (aged 52 
years, onset at the age of 18 years) was more severely 
affected than her son (aged 32 years, onset at the age of 24 
years), all showed, on average, an earlier onset in the youn­
ger than in the older generation. As seen in table 1, such a 
difference was even greater when the analysis was repeated 
excluding the proband of each family.
Our present observation of a mean age at onset 17-19 References 
years earlier, on average, in affected offspring, as compared 
with their parents in multigenerational families (after cor­
rection for a possible bias of ascertainment toward more 
severely affected probands), has apparently not been pre­
viously reported for FSHD. A common criticism of this 
kind of study is that data on age at onset of clinical symp­
toms in earlier generations are not always reliable. The age 
at onset in parents, however, as compared with their 
affected children, was considered by Penrose (1948) for 
the analysis of anticipation in DM, In the present study, 
such information was confirmed in most of the cases 
through clinical examinations and follow-up, in some 
cases for >20 years in our own center. Some affected par­
ents who reported later onset have such a mild phenotype 
that they are currently less handicapped than their affected 
offspring who are, on average, 20-30 years younger. In ad­
dition, in the present analysis, the results observed on the 
basis of age at onset are reinforced by those obtained on 
the basis of age at ascertainment.
Although the present study supports the hypothesis of 
anticipation for FSHD in multigenerational families, this 
disease differs from other autosomal dominant conditions 
with anticipation such as DM and HD, in three aspects:
(a) the lack of difference in the severity of the phenotype 
according to the gender of the transmitting parent; (b) the 
high proportion of cases arising from new mutations— as 
opposed to DM and HD, in which new mutations arc ap­
parently very rare; and (c) the reduced biological fitness.
Interestingly, no statistically significant differences were 
observed for both the age at onset and the age at ascertain-
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